Wolfgang Miesbach: Translating Gene Therapy into Haemophilia Care at EHA 2026
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Honoured to be speaking at EHA 2026 this Friday, 12 June in the ‘Gene engineering and therapy’ session.
In ‘Translating Genetic Innovation into Haemophilia Care’ (P141-2), I’ll explore how three decades of gene therapy development are reshaping not just treatment, but how care itself is organised — from the structure of treatment centres to the way we follow patients across their lifetimes.
Haemophilia has long been a proving ground for genetic medicine, and the lessons here ripple out to many other conditions.
I’ll also reflect on a sobering reality: some gene therapies are being pulled from the market not because they failed patients, but because the business model did.
The future of genetic medicine may depend less on what we can cure than on what our systems are willing to pay for.”
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026
-
Jul 25, 2026, 12:11Salma Abosabie: Honored to Have an Oral Presentation on Thromboinflammation at the ISTH 2026
-
Jul 25, 2026, 12:06Christina Hart: New Review on Coagulation Disorders in Philadelphia Chromosome-Negative MPNs
-
Jul 25, 2026, 11:57Leonard Valentino: Excited to Share The New Perspectives on Hemophilic Arthropathy
-
Jul 25, 2026, 11:49Meaghan O’Donnell: Highlighting Global Gaps in Haemophilia Carrier Registration at ISTH 2026
-
Jul 25, 2026, 11:43Emmanuel J Favaloro: Honored with the JTH Distinguished Peer Review Award